Venexa Tablet
NDC Package 59088-176-54

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Venexa (folic acid) tablets is folic acid is the man-made form of folate. This formulation utilizes a tablet delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-176.

Identification & Billing

NDC Package Code
59088-176-54
Package Description
30 TABLET in 1 BOTTLE, PLASTIC
Product Code
59088-176
11-Digit Billing Format
59088017654
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Venexa
Non-Proprietary Name
Folic Acid
Substance Name
.alpha.-tocopherol Acetate, Dl-; Ascorbic Acid; Calcium Carbonate; Cholecalciferol; Chromium Nicotinate; Cyanocobalamin; Folic Acid; Magnesium Oxide; Manganese Sulfate; Molybdenum; Niacinamide; Pyridoxine Hydrochloride; Riboflavin; Selenium; Thiamine Mononitrate; Vitamin A Acetate; Zinc Oxide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Folic acid is the man-made form of folate. Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-29-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-176-54 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Venexa, a human prescription drug labeled by Puretek Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; calcium carbonate; cholecalciferol; chromium nicotinate; cyanocobalamin; folic acid; magnesium oxide; manganese sulfate; molybdenum; niacinamide; pyridoxine hydrochloride; riboflavin; selenium; thiamine mononitrate; vitamin a acetate; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on January 29, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Folic acid is the man-made form of folate. Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088017654. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-176-54
11-Digit CMS (5-4-2)
59088-0176-54

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.